Institutional investors purchased a net $5.0 million shares of RGLS during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 40.39% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RA CAPITAL MANAGEMENT LLC Bought 4.7 Million shares of Regulus Therapeutics Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 191.7 Thousand shares of Regulus Therapeutics Inc